Weight loss on Cymbalta (duloxetine) is modest and temporary. In short-term clinical trials lasting 8 to 9 weeks, adults lost an average of about 1.1 pounds (0.5 kg), and this effect typically reverses after a few months of continued use. If you’re hoping Cymbalta will drive significant weight loss, the clinical data paints a more complicated picture.
What the First Few Months Look Like
The initial weight drop on Cymbalta happens during the first two months or so of treatment. Across 10 clinical studies analyzed by Johns Hopkins researchers, patients on duloxetine lost an average of 0.5 kg (just over a pound) during the acute treatment phase, while those taking a placebo actually gained a small amount. That difference is statistically real but physically small. Most people wouldn’t notice it on a scale.
The loss likely comes from common early side effects: nausea, reduced appetite, and stomach discomfort. These side effects tend to fade as your body adjusts to the medication, which is also when the weight loss stops. There’s no evidence that Cymbalta meaningfully speeds up your metabolism or burns fat. The drug increases serotonin and norepinephrine activity in the brain, which can temporarily suppress appetite in some people, but this isn’t a reliable or lasting effect.
Weight Tends to Come Back
After the initial dip, the trend reverses. In a 34-week study, patients taking a standard dose (80 mg per day) gained an average of 0.7 kg, which was not meaningfully different from placebo. At a higher dose of 120 mg per day, patients gained about 0.9 kg (roughly 2 pounds), a statistically significant increase compared to placebo. This suggests higher doses are more likely to lead to weight gain over time.
The longest available data comes from a 52-week open-label study, where patients on Cymbalta gained an average of 2.4 pounds (1.1 kg) by the end of the year. In that same 34-week data, 8.6% of patients on the standard dose and 12.8% on the higher dose gained more than 7% of their starting body weight. For someone who weighed 170 pounds at the start, that’s roughly 12 pounds or more.
So the pattern is clear: a small, short-lived weight loss in the first couple of months, followed by gradual weight gain that continues the longer you stay on the medication.
Dose Doesn’t Affect Early Weight Loss
You might assume a higher dose would cause more weight loss, but the clinical data shows no consistent relationship between Cymbalta’s dose and the initial weight drop. The roughly one-pound average loss in the first 8 to 9 weeks was similar across different dosing levels.
Where dose does matter is in the longer term. The 34-week data showed that patients on 120 mg per day gained significantly more weight than those on 80 mg per day. So while starting dose doesn’t predict how much you’ll lose early on, staying on a higher dose increases the likelihood of weight gain later.
How Cymbalta Compares to Other Antidepressants
Among commonly prescribed first-line antidepressants, Cymbalta falls in the middle of the pack for weight effects. A large comparative study estimated that over six months, duloxetine was associated with about 0.34 kg more weight gain than sertraline (Zoloft), putting it in a similar range as venlafaxine (Effexor), another SNRI. Escitalopram (Lexapro) and paroxetine (Paxil) were associated with slightly more weight gain.
Patients on duloxetine had a 10 to 15 percent higher risk of gaining at least 5% of their body weight compared to those on sertraline. The one antidepressant consistently linked to weight loss rather than gain is bupropion (Wellbutrin), which showed a 15 percent reduced risk of that same weight gain threshold. If weight is a primary concern, that distinction is worth knowing.
Weight Changes After Stopping Cymbalta
What happens to your weight after discontinuing Cymbalta is less well-studied. Some people lose weight they gained during treatment, while others experience fluctuations tied to withdrawal symptoms. Cymbalta is known for a particularly difficult discontinuation process that can include nausea, dizziness, and mood changes, all of which can affect eating patterns. There’s no reliable data showing rapid weight loss after stopping, and individual experiences vary widely.
Who Might Actually Lose Weight
While the averages are modest, some individuals do lose more. In pediatric clinical trials, 14 to 16 percent of young patients experienced clinically significant weight loss (defined as losing 3.5% or more of their body weight), compared to about 6 percent on placebo. Adult trials don’t break out this subgroup as clearly, but it’s reasonable to expect a similar pattern: most people lose very little, a small percentage loses a noticeable amount, and another group gains weight, with these effects roughly balancing out in the averages.
If you’ve lost weight in the first few weeks on Cymbalta, the side effects driving that loss (particularly nausea and appetite suppression) are the most likely explanation. That weight change is unlikely to continue or accelerate. Treating Cymbalta as a weight loss tool isn’t supported by the evidence, and the longer-term trend points in the opposite direction.